Cargando…
Current and emerging drugs for the treatment of inflammatory bowel disease
During the last decade a large number of biological agents against tumor necrosis factor-α (TNF-α), as well as many biochemical substances and molecules specifically for the medical treatment of patients with inflammatory bowel disease (IBD), have been developed. This enormous progress was a consequ...
Autores principales: | Triantafillidis, John K, Merikas, Emmanuel, Georgopoulos, Filippos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084301/ https://www.ncbi.nlm.nih.gov/pubmed/21552489 http://dx.doi.org/10.2147/DDDT.S11290 |
Ejemplares similares
-
Crohn's disease of the small bowel, complicated by primary biliary cirrhosis, Hashimoto thyroiditis, and Raynaud's phenomenon: favorable response of all disorders to adalimumab treatment
por: Triantafillidis, John K., et al.
Publicado: (2013) -
The Role of Enteral Nutrition in Patients with Inflammatory Bowel Disease: Current Aspects
por: Triantafillidis, John K., et al.
Publicado: (2015) -
Herbal and plant therapy in patients with inflammatory bowel disease
por: Triantafyllidi, Aikaterini, et al.
Publicado: (2015) -
Gastric Outlet Obstruction due to Cytomegalovirus Infection in an Immunocompromised Patient
por: Panteris, Vasileios, et al.
Publicado: (2009) -
Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease
por: Triantafillidis, John K., et al.
Publicado: (2020)